Teyi Pharmaceutical Group Co.,Ltd (002728.SZ)

CNY 7.68

(0.92%)

Market Cap (In CNY)

3.85 Billion

Revenue (In CNY)

1.06 Billion

Net Income (In CNY)

253.17 Million

Avg. Volume

10.27 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
6.79-13.285714
PE
54.86
EPS
0.14
Beta Value
1.571
ISIN
CNE100001WK6
CUSIP
-
CIK
-
Shares
501976125.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Songqing Xu
Employee Count
-
Website
https://www.tczy.com.cn
Ipo Date
2014-07-31
Details
Teyi Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of proprietary Chinese medicines, and chemical preparations, raw materials, and products in China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular, and digestive system drugs. Its chemical raw materials and products include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co., Ltd. in November 2016. Teyi Pharmaceutical Group Co., Ltd. is based in Taishan, China.